NFKB1 and leukemia: I3C and its metabolite DIM have been found to inhibit both inducible and constitutive NF-κB activation, suppressed the activation of IKK, and prevented the nuclear translocation of p65 NF-κB and NF-κB-dependent gene expression in myeloid and leukemia cells [75–77].